Gene Expression Analysis before and after Treatment with Adalimumab in Patients with Ankylosing Spondylitis Identifies Molecular Pathways Associated with Response to Therapy

The etiology of Ankylosing spondylitis (AS) is still unknown and the identification of the involved molecular pathogenetic pathways is a current challenge in the study of the disease. Adalimumab (ADA), an anti-tumor necrosis factor (TNF)-alpha agent, is used in the treatment of AS. We aimed at ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolcino, Marzia, Tinazzi, Elisa, Pelosi, Andrea, Patuzzo, Giuseppe, Moretta, Francesca, Lunardi, Claudio, Puccetti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406874/
https://www.ncbi.nlm.nih.gov/pubmed/28441778
http://dx.doi.org/10.3390/genes8040127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406874/
https://www.ncbi.nlm.nih.gov/pubmed/28441778
http://dx.doi.org/10.3390/genes8040127

Ejemplares similares